Skip to main content
Home

Primary Menu

  • OUR STRATEGY
    • HOW WE MAKE CANCER BREAKTHROUGHS
    • WHAT WE SUPPORT
    • OUR HISTORY
    • OUR LEADERSHIP
  • OUR IMPACT
    • WHAT SETS US APART
    • CURRENT PROJECTS
    • TIMELINE
  • GET INVOLVED
    • LEADERSHIP GIFTS
    • BECOME A SPONSOR
    • LEGACY PLANNING
    • EVENTS
  • FOR SCIENTISTS
    • AWARD PROGRAMS
    • APPLICATION GUIDELINES
    • GENERATIONS OF INNOVATORS
    • SELECTION COMMITTEES
    • ACCELERATING CANCER CURES
    • FAQ
  • NEWS
  • BROADWAY TICKETS

Donate

  • DONATE

Damon Runyon News

View New Articles By

News

Scientist Bio May 17, 2023
Abigail Overacre-Delgoffe, PhD

Immune-based therapies have revolutionized the way cancer patients are treated; however, most patients do not benefit from these current treatments. Dr. Overacre-Delgoffe seeks to understand why certain patients do not respond and, along with others in the field, has found that the bacteria (microbes) that reside within the gut can impact this response across cancer types. Dr.

Read More
Scientist Bio May 17, 2023
Liudmila Andreeva, PhD

Dr. Andreeva focuses on structural and mechanistic aspects of inflammatory pathways underlying cancer and multiple other pathologies. Inflammation is an early response to various infections and damage initiated by the immune system.

Read More
Scientist Bio May 17, 2023
Tyler Starr, PhD

Many viruses that have devastating results in humans, such as SARS-CoV-2, HIV, and influenza, originate from pathogens in non-human animal species. These viruses can play a direct role in enabling the progression of viral-specific c

Read More
Scientist Bio May 5, 2023
Carolina Trenado-Yuste, PhD

Breast cancer is the most frequent cancer in women and the second-leading cause of cancer deaths in women worldwide. Triple-negative breast cancer is among the most aggressive subtypes; its name refers to the fact that it lacks all three primary markers of breast cancer, making it particularly challenging to detect and treat. Although our ability to detect early-stage breast cancer has improved substantially over the past few decades, anticipating whether and how fast a tumor will progress to metastatic disease remains challenging. Dr.

Read More
Scientist Bio May 5, 2023
Youngmu (Nick) Shin, PhD

Cells in our body communicate with each other in a highly selective manner. These cell-cell interactions form the basis of numerous physiological functions, such as neuronal wiring and immune recognition. Dr. Shin plans to explore the general principles of cell-cell communication by constructing a synthetic synapse and studying its organization and functional diversity. His findings will elucidate the mechanisms that organize cell-cell interfaces involved in immune cell recognition of cancer and in the cell-type transitions associated with cancer and metastasis.

Read More
Scientist Bio May 5, 2023
Nicholas C. Lammers, PhD

In both embryonic development and disease, the same genetic mutation can lead to highly variable outcomes in different individuals. Dr. Lammers aims to shed light on the drivers of this nongenetic variability using the developing zebrafish embryo as a model system. By combining fluorescence microscopy and single-cell sequencing, he will test whether subtle differences in gene expression within individual cells can explain why some embryos with a given genetic mutation survive to adulthood, while others perish within the first 24 hours of their development.

Read More
Scientist Bio February 3, 2023
Nicholas P. Lesner, PhD

Ammonia, a waste product of cellular activity, is cleared from the body by the liver and kidneys through a process known as the urea cycle. During the urea cycle, ammonia is converted to urea, and arginine (an amino acid) is generated. When liver cells become cancerous, the urea cycle pathway stops functioning and cancer cells must import arginine from outside the cell. When cancer cells are prevented from importing arginine (via removal of arginine from the diet or genetic removal of the transporter), tumors do not grow, suggesting that arginine is critical for cells.

Read More
Scientist Bio February 3, 2023
Claudia A. Rivera Cifuentes, PhD

Endogenous retroviruses are viral elements of the human genome derived from retroviral infections of distant ancestors. Recent findings support the idea that these elements can cause immune system activation and inflammation. However, the crosstalk between endogenous retroviruses and the gut microbes that control immunity within the gut-and how abnormalities in this dialogue lead to inflammatory disorders-is not well understood.

Read More
Scientist Bio February 3, 2023
McLane Watson, PhD

Cancer immunotherapy has revolutionized the way we treat cancer; however, it is only successful in a small subset of patients. Optimally functioning CD8 T cells, the specialized killers of the immune system, are key to the success of cancer immunotherapies. While CD8 T cell function is highly influenced by their metabolism, little is understood about how metabolism changes the function of these cells. Dr. Watson hypothesizes that metabolism affects CD8 T cell function by altering how tightly its DNA is packaged (its epigenetics), leading to altered gene expression.

Read More
Scientist Bio February 3, 2023
Marie R. Siwicki, PhD

Neutrophils are important anti-microbial cells within the innate immune system. Recently, it has been shown that neutrophils can perform diverse functions, taking on both pro-inflammatory and pro-healing roles in response to tissue injury or insult. Dr. Siwicki's [Dale F. and Betty Ann Frey Fellow] goal is to understand how different neutrophil subtypes or states function to balance inflammatory versus regenerative processes, ultimately influencing tissue health and cancer.

Read More

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page Next ›
  • Last page Last »

ABOUT

Annual Reports + Report Cards
Financial Overview
Our Team

CONNECT

1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006

Damon Runyon Cancer Research Foundation on Facebook Damon Runyon Cancer Research Foundation on LinkedIn Damon Runyon Cancer Research Foundation on BlueSky Damon Runyon Cancer Research Foundation on X Damon Runyon Cancer Research Foundation on Instagram Damon Runyon Cancer Research Foundation on Youtube

    

© COPYRIGHT DAMON RUNYON. ALL RIGHTS RESERVED

PRIVACY POLICY